Caprock Group, Inc. Biogen Inc. Transaction History

Caprock Group, Inc.

$2.43 Billion
Q2 2024

A detailed history of Caprock Group, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Caprock Group, Inc. holds 2,681 shares of BIIB stock, worth $465,930. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,681

Previous 2,936 8.69%

Holding current value

$465,930

Previous $633,000 1.9%

% of portfolio

0.03%

Previous 0.04%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$190.52 - $236.72 $48,582 - $60,363	-255 Reduced 8.69%	2,681 $621,000
Q1 2024 Apr 29, 2024	SELL	$212.02 - $267.71 $546,375 - $689,888	-2,577 Reduced 46.74%	2,936 $633,000
Q4 2023 Jan 18, 2024	BUY	$222.59 - $267.94 $95,045 - $114,410	427 Added 8.4%	5,513 $1.43 Million
Q3 2023 Oct 18, 2023	SELL	$253.3 - $285.89 $69,910 - $78,905	-276 Reduced 5.15%	5,086 $1.31 Million
Q2 2023 Aug 10, 2023	BUY	$275.25 - $318.06 $26,148 - $30,215	95 Added 1.8%	5,362 $1.53 Million
Q1 2023 Apr 26, 2023	BUY	$256.56 - $292.34 $34,635 - $39,465	135 Added 2.63%	5,267 $1.46 Million
Q4 2022 Jan 23, 2023	BUY	$252.44 - $306.72 $50,488 - $61,344	200 Added 4.06%	5,132 $0
Q3 2022 Nov 07, 2022	SELL	$194.69 - $268.46 $15,769 - $21,745	-81 Reduced 1.62%	4,932 $1.32 Million
Q2 2022 Jul 26, 2022	BUY	$187.54 - $223.02 $108,398 - $128,905	578 Added 13.03%	5,013 $1.02 Million
Q1 2022 Apr 12, 2022	BUY	$193.77 - $244.14 $23,252 - $29,296	120 Added 2.78%	4,435 $934,000
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $47,471 - $61,007	-212 Reduced 4.68%	4,315 $1.04 Million
Q3 2021 Oct 07, 2021	BUY	$282.99 - $369.05 $66,219 - $86,357	234 Added 5.45%	4,527 $1.28 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $83,139 - $133,121	-321 Reduced 6.96%	4,293 $1.49 Million
Q1 2021 Apr 29, 2021	BUY	$242.95 - $284.63 $485 - $569	2 Added 0.04%	4,614 $1.29 Million
Q4 2020 Jan 29, 2021	SELL	$236.26 - $355.63 $19,609 - $29,517	-83 Reduced 1.77%	4,612 $1.13 Million
Q3 2020 Oct 29, 2020	BUY	$264.77 - $305.71 $24,623 - $28,431	93 Added 2.02%	4,695 $1.33 Million
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $4,655 - $6,165	18 Added 0.39%	4,602 $1.23 Million
Q1 2020 Apr 28, 2020	BUY	$268.85 - $341.04 $6,452 - $8,184	24 Added 0.53%	4,584 $1.45 Million
Q4 2019 Feb 04, 2020	BUY	$220.06 - $304.07 $7,922 - $10,946	36 Added 0.8%	4,560 $1.35 Million
Q3 2019 Oct 31, 2019	SELL	$217.44 - $243.88 $1,739 - $1,951	-8 Reduced 0.18%	4,524 $1.05 Million
Q2 2019 Jul 23, 2019	BUY	$219.29 - $241.72 $284,199 - $313,269	1,296 Added 40.05%	4,532 $1.06 Million
Q1 2019 Apr 12, 2019	BUY	$216.71 - $338.96 $4,550 - $7,118	21 Added 0.65%	3,236 $765,000
Q4 2018 Jan 29, 2019	BUY	$278.5 - $352.75 $6,684 - $8,466	24 Added 0.75%	3,215 $967,000
Q3 2018 Oct 17, 2018	BUY	$293.51 - $383.83 $12,914 - $16,888	44 Added 1.4%	3,191 $1.13 Million
Q2 2018 Jul 23, 2018	BUY	$257.52 - $306.91 $19,056 - $22,711	74 Added 2.41%	3,147 $913,000
Q1 2018 Apr 23, 2018	SELL	$260.13 - $367.91 $16,648 - $23,546	-64 Reduced 2.04%	3,073 $841,000
Q4 2017 Jan 17, 2018	SELL	$307.64 - $344.58 $4,922 - $5,513	-16 Reduced 0.51%	3,137 $1.05 Million
Q3 2017 Oct 23, 2017	BUY	$281.15 - $329.69 $886,465 - $1.04 Million	3,153	3,153 $987,000

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Biogen Inc. Transaction History